The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Related Posts
CEO and CFO suddenly depart AI nuclear power upstart Fermi
The startup, co-founded by former U.S. Energy Secretary Rick Perry, has faced headwinds with its AI campus in…
Hitachi bets on industrial expertise to win the physical AI race
Physical AI–the branch of artificial intelligence that controls robots and industrial machinery in the real world–has a hierarchy…
AWS boss explains why investing billions in both Anthropic and OpenAI is an OK conflict
AWS has an ingrained culture of handling coopetition, he explained, because the cloud giant also competes with its…
